MIRM Earnings

Quarterly EPS
$-0.49
Q4 2024
$-0.30
Q1 2025
$-0.12
Q2 2025
$0.06
Q3 2025
$-0.11
Q4 2025
$-13.43
Q1 2026
$-1.06
Q2 2026
$-0.62
Q3 2026
Latest Revenue185.7M
Latest Net Income-40766000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.62185.7M-40766000+39.6%-1,133.3%
Q2 2026-$1.06176.2M-67227000+37.9%-783.3%
Q1 2026-$13.43159.9M-790155000+43.3%-4,376.7%
Q4 2025-$0.11148.9M-5730000+49.8%+77.6%
Q3 2025$0.06133.0M2.9M+47.2%+120.0%
Q2 2025-$0.12127.8M-5861000+64.1%+76.9%
Q1 2025-$0.30111.6M-14677000+61.2%+44.4%
Q4 2024-$0.4999.4M-23790000+42.9%+35.5%
Q3 2024-$0.3090.4M-14235000——
Q2 2024-$0.5277.9M-24638000——
Q1 2024-$0.5469.2M-25279000——
Q4 2023-$0.7669.6M-35659000——
Mirum Pharmaceuticals (MIRM) — Earnings